✦ LIBER ✦

Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis

✍ Scribed by M.R. Wills; Angela Fairney; Z. Varghese; G.L.V. Tatler; Rosemarie A. Baillod; J.F. Moorhead

Book ID: 115820326
Publisher: Elsevier Science
Year: 1974
Tongue: English
Weight: 507 KB
Volume: 57
Category: Article
ISSN: 0009-8981
DOI: 10.1016/0009-8981(74)90181-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship of predialytic intact parat

Relationship of predialytic intact parathyroid hormone on secondary hyperparathyroidism in chronic maintenance haemodialysis patients

✍ SATOSHI ETOH; TOSHIAKI MURATA; YOSHIYUKI HASEGAWA; YOSHITO MIYAHARA; ATUNORI ISH 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Red-Cell Organic Phosphates in Patients

Red-Cell Organic Phosphates in Patients with Chronic Renal Failure on Maintenance Haemodialysis

✍ R. K. Chillar; Jane F. Desforges 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Atrial natriuretic peptide (ANP) in pati

Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis

✍ R. de Châtel; J. Makó; M. Tóth; I. Barna; R. E. Lang 📂 Article 📅 1991 🏛 Springer Netherlands 🌐 English ⚖ 381 KB

The calcimimetic agent KRN 1493 lowers p

The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis

✍ Naro Ohashi; Toshihiko Uematsu; Satoru Nagashima; Mitsutaka Kanamaru; Akashi Tog 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Serum gastrin levels in patients with re

Serum gastrin levels in patients with renal failure on maintenance haemodialysis and after successful kidney transplantation

✍ Angelo Muolo; Oreste Ghidini; Mario Tonon; Ettore Galvani; Pier Francesco Baratt 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 631 KB

Oral pharmacokinetics of pirenzepine in

Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis

✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1